CLINICAL_TRIALS
trial_result
· 2024-06-05
Clinical Trial Update: PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns [Phase 3]
Summary
This update reports the completion of a Phase 3 trial evaluating erythropoietin for hypoxic-ischemic encephalopathy in newborns.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Sydney | Conditions: Hypoxic-Ischemic Encephalopathy | Phase 3 | Status: COMPLETED